Method for treating substance abuse withdrawal
AssigneeEli Lilly and Company
InventorsMary J. Kallman, Kurt Rasmussen
Life of this patent
Estimating the term…
Abstract
This invention provides a method for treating a condition resulting from the cessation or withdrawal of tobacco or nicotine, opioids, ethanol or combinations thereof comprising administering an effective amount of 4-chloro-5-(imidazoline-2-y(amino)-6-methoxy-2-methylpyrimidine.
Claims9
A method for treating a condition resulting from the cessation or withdrawal of opioids comprising administering to a mammal in need of such treatment, an effective dose of 4-chloro-5-(imidazoline-2-ylamino)-6-methoxy-2-methylpyrimidine, or a pharmaceutically acceptable salt thereof.
A method for inhibiting one or more symptoms from the cessation or withdrawal of opioids comprising administering to a mammal in need of such treatment, an effective dose of 4-chloro-5-(imidazoline-2-ylamino)-6-methoxy-2-methylpyrimidine, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.